Stem cells in human neurodegenerative disorders--time for clinical translation?

By O. Lindvall, Z. Kokaia. Journal of Clinical Investigation, 2010

616 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Developmental Neuroscience, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/bc277cb3ce5108efd32525a71743b867a3b56f86

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. G. Martino
2. S. Pluchino
3. M. Schwartz
4. Fred H. Gage
5. Beate Winner
6. James Bradley Aimone
7. Hongjun Song
8. Wei Deng

In Developmental Neuroscience

1. S. Pluchino
2. G. Martino
3. M. Schwartz
4. Beate Winner
5. Fred H. Gage
6. Zacharias Kohl
7. L. Bonfanti
8. James Bradley Aimone

In Molecular Biology

1. M. Schwartz
2. G. Martino
3. Fred H. Gage
4. L. Bonfanti
5. S. Pluchino
6. Hongjun Song

Citations in the corpus

• BRAIN REGENERATION IN PHYSIOLOGY AND PATHOLOGY: THE IMMUNE SIGNATURE DRIVING THERAPEUTIC PLASTICITY OF NEURAL STEM CELLS (2011, background): “In PD, a disease characterized by an extensive loss of dopamine (DA) neurons in the substantia nigra pars compacta and their terminals in the striatum (24), donor cells are transplanted directly into the target region (the striatum) to circumvent the problem of long-distance neuritic growth in the a”
• Neurodegenerative disease and adult neurogenesis (2011, background): “Although both endogenous NSCs and fetal cell transplantation have been tested up to clinical studies (extensively reviewed in Lindvall & Kokaia, 2010), we will limit our review to the aspects of endogenous generation of new neurons in the adult brain.”